These data are in line with the results obtained in the present study, in which circulating levels of PARC have a numerical tendency to be higher in COPD subjects compared to other groups, though this trend did not reach statistical significance due to the high biological variability between subjects and the limited number of cases available for analysis.
← all excerpts
Vascular disease in COPD: Systemic and pulmonary expression of PARC (Pulmonary and Activation-Regulated Chemokine).
1
—
—